Skip to main content
中科美菱 logo

中科美菱 — Investor Relations & Filings

Ticker · 920992 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2022-12-14 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920992

About 中科美菱

http://www.zkmeiling.com/

Zhongke Meiling Cryogenics Co., Ltd., branded as Meling Biology & Medical, specializes in the research, development, and manufacturing of low-temperature storage solutions and laboratory equipment. The product portfolio includes ultra-low temperature freezers capable of reaching -86°C and -164°C, medical refrigerators, blood bank refrigerators, and pharmacy refrigerators. The company also provides cold chain logistics equipment and biological sample bank management systems. Its technical focus centers on advanced cryogenic cooling systems designed for the preservation of biological materials, vaccines, and medical supplies. These solutions are utilized by research institutes, healthcare facilities, and pharmaceutical organizations requiring precise temperature control and long-term storage reliability.

Recent filings

Filing Released Lang Actions
关于拟变更注册资本及修订公司章程公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed change in registered capital and the revision of the company's articles of association. It includes references to regulatory compliance, stock issuance, and board resolutions. The document is relatively short (1288 characters) and does not contain detailed financial statements or comprehensive financial data. It is primarily a regulatory announcement about corporate governance changes and capital structure adjustments, not a full financial report or detailed capital update. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not neatly fit into other specific categories.
2022-12-14 Chinese
关于修订年度业绩激励基金实施方案的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the revision of the company's Annual Performance Incentive Fund Implementation Plan. It details the board meeting approvals, specific amendments to the incentive plan, independent director opinions, and sponsor institution opinions. The document does not contain financial statements or detailed financial performance data. It is a corporate governance-related announcement about management incentive plans and their approval process, not a full annual report or financial report. It is not a proxy solicitation or voting results announcement either. Given the content focuses on board decisions and management incentive scheme revisions, the best fitting category is Board/Management Information (MANG). The document length is 2633 characters, which is relatively short and consistent with an announcement rather than a full report.
2022-12-14 Chinese
以自筹资金预先投入募集资金投资项目及支付发行费用情况鉴证报告
Regulatory Filings
2022-12-14 Chinese
关于延长公司股东股份锁定期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the extension of the lock-up period for the controlling shareholder's shares. It details shareholder commitments, lock-up terms, and the extension of the lock-up period for specific shares. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The document is a regulatory announcement about shareholding restrictions and lock-up period extension, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Major Shareholding Notification (MRQ) because it is about lock-up extension rather than shareholding threshold changes.
2022-11-24 Chinese
关于公司聘任首席合规官的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a Chief Compliance Officer at the company 中科美菱低温科技股份有限公司. It details the board meeting decision, the qualifications and background of the appointed individual, and compliance with regulatory requirements. There is no financial data, no report attached or referenced, and no mention of financial results or filings. This fits the category of Board/Management Information (MANG), as it concerns a change in senior management roles.
2022-11-24 Chinese
独立董事关于第三届董事会第十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the independent directors of Zhongke Meiling Cryogenics Co., Ltd. regarding their independent opinions on matters discussed at the 15th meeting of the third board of directors. It includes the appointment of the Chief Compliance Officer and references compliance with company law and securities regulations. The content is a statement of opinion and approval related to board decisions, not a full report or financial statement. It is not an annual report, audit report, earnings release, or any financial report. It is also not a regulatory filing or certification letter but a board/management information announcement about a management appointment. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on board matters, supporting this classification.
2022-11-24 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.